跳至主要内容
临床试验/ISRCTN92186858
ISRCTN92186858已完成未知

Can high-dose vitamin D supplementation reduce blood pressure and markers of cardiovascular risk in older people with isolated systolic hypertension? A randomised, double-blind, parallel group placebo controlled trial

niversity of Dundee (UK)0 个研究点目标入组 180 人开始时间: 2008年8月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged greater than or equal to 70 years, either sex
  • 2. Office systolic blood pressure (BP) greater than 140 mmHg
  • 3. Serum 25 hydroxy vitamin D less than 75 nmol/

排除标准

  • 1. Hypertension known to be due to a correctable underlying medical or surgical cause
  • 2. Diastolic blood pressure greater than 90 mmHg
  • 3. Systolic blood pressure greater than 180 mmHg
  • 4. Estimated glomerular filtration rate less than 40 ml/min (by four-variable modification of diet in renal disease rate [MDRD] equation)
  • 5. Liver function tests (alanine aminotransferase [ALT], bilirubin, alkaline phosphatase) greater than 3 x normal
  • 6. Corrected calcium greater than 2.60 mmol/L or less than 2.15 mmol/L
  • 7. Known metastatic malignancy or sarcoidosis
  • 8. Clinical diagnosis of osteomalacia
  • 9. History of renal calculi
  • 10. Diagnosis of heart failure with left ventricular systolic dysfunction
  • 11. Atrial fibrillation
  • 12. Already taking vitamin D supplements (consumption of fish oils will not be a contraindication to enrolment)
  • 13. Unable to give written informed consent

研究者

发起方
niversity of Dundee (UK)

相似试验